AstraZeneca announced it has received FDA approval for the self-administration of benralizumab in a prefilled, single-use auto-injector pen for patients with severe eosinophilic asthma, according to a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback